Marketing

The future of pharma marketing with Real Chemistry


Join us for an eye-opening conversation with Eric Solomon, Practice Leader for Paid Media activation at AI-industry innovator at Real Chemistry.

Recorded following Digital Pharma East, Solomon kicks off this episode by demystifying the prevailing idea that pharma marketing is slow to innovate owing to strict regulatory environments. Instead, he argues that – in large part thanks to the role of digital and social media – pharma has actually risen to the fore of innovation in the media space in recent years.

Turning attentions to the future, Solomon also shares his predictions for the next five years, pointing to the increasing role of real-world data and AI-driven solutions in media planning. Here, he discusses how the industry is likely to shift from reactive strategies to predictive insights in areas such as audience intelligence, marketplace trends and prescribing decisions.

For all this, as well as Solomon's thoughts on how advancements in AI and privacy-compliant data are transforming the way pharma delivers personalized messages to target audiences, tune into the full episode now!

The editorial staff had no role in this post's creation.